About Matthew Ercolani
Form D filings for Rivermark Medical in 2024 list Matthew Ercolani as director.
Matthew Ercolani first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Ercolani in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Ercolani works with at each company, as listed on that company's latest Form D.
Rivermark Medical, Inc. · Form D, Oct 11, 2024
JB
Josh Baltzell
Director
CM
Carter Meyer
Director
AD
Anand Doraiswamy
Executive officer and director
SB
Scott Button
Director
AK
Adam Kadlec
Chief Executive Officer and President, director
JB
Joseph Biller
Director